Thomas Löhr

We’re thrilled to announce the launch of Bind Research, the UK’s first not-for-profit Focused Research Organisation, with long-term support from the Department for Science, Innovation and Technology’s Research Ventures Catalyst Programme, industry, and charities.

Today @gogs-k.bsky.social, @tlhr.bsky.social, and I are launching @bindresearch.org, a UK-based not-for-profit research startup to deliver publicly–available tools and datasets to make intrinsically disordered proteins druggable. 🍝 💊🧲 💻 🦠

Delighted to announce @tlhr.bsky.social, @g-heller.bsky.social and I are building the UK’s first FRO @bindresearch.org with the goal of making disordered proteins druggable. Interested in doing breakthrough open science in an innovative organisation in Central London? We’d love to hear from you!

Find out more and reach out at bindresearch.org! 🍝💻

On the #CompChem side, we’ll be using multi-scale simulations, #AI, and data from NMR experiments to build models that will make targeting disordered proteins viable.

Incredibly excited to be starting @bindresearch.org with @gogs-k.bsky.social and @g-heller.bsky.social! We are a not-for-profit research startup based in London, creating tools and datasets to make disordered proteins druggable.